Application no. and date | 12787111.9 (espacenet) (Federated) (European Patent Register), 20121107 | Patent/reg. no. and date | DK/EP 2780039, 20171129 | Publication date | 20140924 | Priority no. and date | US 201161561255 P, 20111117, US 201261676423 P, 20120727 | EP pub. no. and date |
EP 2780039 20140924 | Effective date | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | Applicant ref. no. | P81704668DK00E | Inventor | MADERNA, Andreas, 54 Pyngyp Road
Stony Point, New York 10980, US, STROP, Pavel, 130 Barneson Avenue 4
San Mateo, California 94402, US, DOROSKI, Matthew David, 52 Church Street Apartment 2
Mystic, Connecticut 06355, US, O'DONNELL, Christopher John, 71 Oxford Court
Mystic, Connecticut 06355, US, SUBRAMANYAM, Chakrapani, 314 Great Pond Road
South Glastonbury, Connecticut 06073, US, VETELINO, Beth Cooper, 368 Denison Hill Road
North Stonington, Connecticut 06359, US, DUSHIN, Russell George, 2 Johnny Cake Hill Road
Old Lyme, Connecticut 06371, US, GRAZIANI, Edmund, Idris, 497 South Pascack Road
Chestnut Ridge, NY 10977, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 47/50 (2017.01) | Title | Cytotoksiske peptider og antistof-lægemiddel-konjugater deraf | Int. application no. | IB2012056224 | Int. publication no. | WO2013072813 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|